Chan L - Search Results

1

Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia.

Koeberl DD, Sun B, Bird A, Chen YT, Oka K, Chan L. Koeberl DD, et al. Among authors: chan l. Mol Ther. 2007 Jul;15(7):1253-8. doi: 10.1038/sj.mt.6300188. Epub 2007 May 15. Mol Ther. 2007. PMID: 17505475 Free article.

2

Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.

Oka K, Belalcazar LM, Dieker C, Nour EA, Nuno-Gonzalez P, Paul A, Cormier S, Shin JK, Finegold M, Chan L. Oka K, et al. Among authors: chan l. Gene Ther. 2007 Feb;14(3):191-202. doi: 10.1038/sj.gt.3302819. Epub 2006 Sep 7. Gene Ther. 2007. PMID: 16957769 Free PMC article.

3

Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.

Crane B, Luo X, Demaster A, Williams KD, Kozink DM, Zhang P, Brown TT, Pinto CR, Oka K, Sun F, Jackson MW, Chan L, Koeberl DD. Crane B, et al. Among authors: chan l. Gene Ther. 2012 Apr;19(4):443-52. doi: 10.1038/gt.2011.86. Epub 2011 Jun 9. Gene Ther. 2012. PMID: 21654821

4

Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.

Pastore L, Belalcazar LM, Oka K, Cela R, Lee B, Chan L, Beaudet AL. Pastore L, et al. Among authors: chan l. Gene. 2004 Mar 3;327(2):153-60. doi: 10.1016/j.gene.2003.11.024. Gene. 2004. PMID: 14980712

5

Construction and characterization of helper-dependent adenoviral vectors for sustained in vivo gene therapy.

Oka K, Chan L. Oka K, et al. Among authors: chan l. Methods Mol Med. 2005;108:329-50. doi: 10.1385/1-59259-850-1:329. Methods Mol Med. 2005. PMID: 16028693

6

Helper-dependent adenoviral vectors.

Oka K, Chan L. Oka K, et al. Among authors: chan l. Curr Protoc Mol Biol. 2005 Feb;Chapter 16:Unit 16.24. doi: 10.1002/0471142727.mb1624s69. Curr Protoc Mol Biol. 2005. PMID: 18265354

7

Helper-dependent adenoviral vectors.

Oka K, Chan L. Oka K, et al. Among authors: chan l. Curr Protoc Hum Genet. 2005 Nov;Chapter 12:Unit 12.13. doi: 10.1002/0471142905.hg1213s47. Curr Protoc Hum Genet. 2005. PMID: 18428374

8

Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.

Samson SL, Gonzalez EV, Yechoor V, Bajaj M, Oka K, Chan L. Samson SL, et al. Among authors: chan l. Mol Ther. 2008 Nov;16(11):1805-12. doi: 10.1038/mt.2008.198. Epub 2008 Sep 9. Mol Ther. 2008. PMID: 18781141 Free PMC article.

9

Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.

Nomura S, Merched A, Nour E, Dieker C, Oka K, Chan L. Nomura S, et al. Among authors: chan l. Gene Ther. 2004 Oct;11(20):1540-8. doi: 10.1038/sj.gt.3302310. Gene Ther. 2004. PMID: 15269711

10

Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector.

Oka K, Mullins CE, Kushwaha RS, Leen AM, Chan L. Oka K, et al. Among authors: chan l. Gene Ther. 2015 Jan;22(1):87-95. doi: 10.1038/gt.2014.85. Epub 2014 Sep 18. Gene Ther. 2015. PMID: 25231173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,144 results

Search Page

Filters